Canakinumab (Ilaris)
Canakinumab is an interleukin-1β (IL-1β) blocker, which works to suppress the production of an inflammatory protein. Increased levels of IL-1β cause inflammation resulting in symptoms such as fever, joint pain, and rashes. Canakinumab stops this inflammatory response
